Publications

  1. Temesgen Z, Assi M, Shweta FNU, Vergidis P, Rizza SA, Bauer PR, Pickering BW, Razonable RR, Libertin CR, Burger CD, Orenstein R, Vargas HE, Palraj R, Dababneh AS, Chappell G, Chappell D, Ahmed O, Sakemura R, Durrant C, Kenderian SS, Badley AD. GM-CSF Neutralization With Lenzilumab in Severe COVID-19 Pneumonia: A Case-Cohort Study. Mayo Clin Proc. 2020 Nov; 95 (11):2382-2394 Epub 2020 Sept 03
    View PubMed
  2. El Helou G, Lahr B, Razonable R. Absolute lymphocyte count as marker of cytomegalovirus and allograft rejection: Is there a "Safe Corridor" after kidney transplantation? Transpl Infect Dis. 2020 Oct 9; e13489 Epub 2020 Oct 09
    View PubMed
  3. Pennington KM, Dykhoff HJ, Yao X, Sangaralingham LR, Shah ND, Peters SG, Barreto JN, Razonable RR, Kennedy CC. The Impact of Antifungal Prophylaxis in Lung Transplant Recipients. Ann Am Thorac Soc. 2020 Sep 23 Epub 2020 Sept 23
    View PubMed
  4. Razonable RR, Marshall WF 3rd, Stevens RW, Kumar S, Murad MH, Wilson WR. Rapid Appraisal System for COVID-19 Medical Information. Mayo Clin Proc. 2020 Sep; 95 (9S):S26-S28 Epub 2020 June 22
    View PubMed
  5. Razonable RR, Carmona EM, Vergidis P, Wilson JW, Marshall WF 3rd. Clinical Guidance and the Delivery of Care for Patients With Coronavirus Disease 2019. Mayo Clin Proc. 2020 Sep; 95 (9S):S23-S25 Epub 2020 June 23
    View PubMed
  6. Suh GA, Shah AS, Kasten MJ, Virk A, Domonoske CL, Razonable RR. Avoiding a Medical Education Quarantine During the Pandemic. Mayo Clin Proc. 2020 Sep; 95 (9S):S63-S65 Epub 2020 June 20
    View PubMed
  7. Singh P, Razonable RR, Lorenz EC, DiCaudo DJ, Sukov WR, Bridges AG, Alkhateeb HB, Hogan WJ, Klomjit N, Thirunavukkarasu S, Amer H, Kudva YC, Khamash H, Stegall M, Kukla A. Chronic graft-versus-host disease in pancreas after kidney transplant recipients - An unrecognized entity. Am J Transplant. 2020 Aug 17 [Epub ahead of print]
    View PubMed
  8. Pennington KM, Baqir M, Erwin PJ, Razonable RR, Murad MH, Kennedy CC. Antifungal prophylaxis in lung transplant recipients: A systematic review and meta-analysis. Transpl Infect Dis. 2020 Aug; 22 (4):e13333 Epub 2020 June 16
    View PubMed
  9. Singh N, Winston DJ, Razonable RR, Lyon GM, Silveira FP, Wagener MM, Limaye AP. Risk factors for viremia in CMV- recipient seronegative donor seropositive liver transplant recipients who receive preemptive antiviral therapy. J Infect Dis. 2020 Jul 29 Epub 2020 July 29
    View PubMed
  10. Singh N, Winston DJ, Razonable RR, Lyon GM, Silveira FP, Wagener MM, Limaye AP. Cost effectiveness of preemptive therapy versus prophylaxis in a randomized clinical trial for the prevention of CMV disease in seronegative liver transplant recipients with seropositive donors. Clin Infect Dis. 2020 Jul 27 Epub 2020 July 27
    View PubMed
  11. Wagner T, Shweta F, Murugadoss K, Awasthi S, Venkatakrishnan AJ, Bade S, Puranik A, Kang M, Pickering BW, O'Horo JC, Bauer PR, Razonable RR, Vergidis P, Temesgen Z, Rizza S, Mahmood M, Wilson WR, Challener D, Anand P, Liebers M, Doctor Z, Silvert E, Solomon H, Anand A, Barve R, Gores G, Williams AW, Morice WG 2nd, Halamka J, Badley A, Soundararajan V. Augmented curation of clinical notes from a massive EHR system reveals symptoms of impending COVID-19 diagnosis. Elife. 2020 Jul 7; 9 Epub 2020 July 07
    View PubMed
  12. Vijayvargiya P, Esquer Garrigos Z, Castillo Almeida NE, Gurram PR, Stevens RW, Razonable RR. Treatment Considerations for COVID-19: A Critical Review of the Evidence (or Lack Thereof). Mayo Clin Proc. 2020 Jul; 95 (7):1454-1466 Epub 2020 Apr 30
    View PubMed
  13. Razonable RR, Pennington KM, Meehan AM, Wilson JW, Froemming AT, Bennett CE, Marshall AL, Virk A, Carmona EM. A Collaborative Multidisciplinary Approach to the Management of Coronavirus Disease 2019 in the Hospital Setting. Mayo Clin Proc. 2020 Jul; 95 (7):1467-1481 Epub 2020 May 30
    View PubMed
  14. Razonable RR, Marshall WF, Stevens RW, Kumar S, Murad MH, Wilson WR. Mayo Clinic strategies for COVID-19 rapid appraisal system for COVID-19 medical information Mayo Clinic Proceeding. 2020.
  15. El Helou G, Razonable R. Next-generatino Sequencing to Assess Cytomegalovirus Viral Populations During the Course of CMV Infection American Transplant Congress, Philadelphia, PA. 2020.
  16. Singh N, Winston DJ, Razonable RR, Lyon GM, Silveira FP, Wagener MM, Stevens-Ayers T, Edmison B, Boeckh M, Limaye AP. Effect of Preemptive Therapy vs Antiviral Prophylaxis on Cytomegalovirus Disease in Seronegative Liver Transplant Recipients With Seropositive Donors: A Randomized Clinical Trial. JAMA. 2020 Apr 14; 323 (14):1378-1387
    View PubMed
  17. Vijayvargiya P, Garrigos ZE, Rodino KG, Razonable RR, Abu Saleh OM. Clostridium paraputrificum septic arthritis and osteomyelitis of shoulder: A case report and review of literature. Anaerobe. 2020 Apr; 62:102105 Epub 2019 Oct 01
    View PubMed
  18. Razonable RR, Inoue N, Pinninti SG, Boppana SB, Lazzarotto T, Gabrielli L, Simonazzi G, Pellett PE, Schmid DS. Clinical Diagnostic Testing for Human Cytomegalovirus Infections. J Infect Dis. 2020 Mar 5; 221 (Supplement_1):S74-S85
    View PubMed
  19. Melia MT, Paez A, Reid G, Chirch LM, Luther VP, Blackburn BG, Perez F, Abdoler E, Kaul DR, Rehm S, Harik N, Barsoumian A, Person AK, Yun H, Beckham JD, Boruchoff S, Cariello PF, Cutrell JB, Graber CJ, Lee DH, Maziarz E, Paras ML, Razonable RR, Ressner R, Chen A, Chow B, Escota G, Herc E, Johnson A, Maves RC, Nnedu O, Clauss H, Kulkarni P, Pottinger PS, Serpa JA, Bhowmick T, Bittner M, Wooten D, Casanas B, Shnekendorf R, Blumberg EA. The Struggling Infectious Diseases Fellow: Remediation Challenges and Opportunities. Open Forum Infect Dis. 2020 Mar; 7 (3):ofaa058 Epub 2020 Feb 18
    View PubMed
  20. Meesing A, Germer JJ, Yao JD, Gartner ML, Digmann BJ, Razonable RR. Differences in Duration and Degree of Cytomegalovirus DNAemia Observed With Two Standardized Quantitative Nucleic Acid Tests and Implications for Clinical Care. J Infect Dis. 2020 Jan 2; 221 (2):251-255
    View PubMed
  21. Abad CL, Razonable RR. Prevention and treatment of tuberculosis in solid organ transplant recipients. Expert Rev Anti Infect Ther. 2020 Jan; 18 (1):63-73 Epub 2019 Dec 18
    View PubMed
  22. Razonable RR. Cytomegalovirus in Solid Organ Transplant Recipients: Clinical Updates, Challenges and Future Directions. Curr Pharm Des. 2020; 26 (28):3497-3506
    View PubMed
  23. Abad CLR, Deziel PJ, Razonable RR. Treatment of latent TB Infection and the risk of tuberculosis after solid organ transplantation: Comprehensive review. Transpl Infect Dis. 2019 Dec; 21 (6):e13178 Epub 2019 Oct 01
    View PubMed
  24. El Helou G, Razonable RR. Safety considerations with current and emerging antiviral therapies for cytomegalovirus infection in transplantation. Expert Opin Drug Saf. 2019 Nov; 18 (11):1017-1030 Epub 2019 Sept 06
    View PubMed
  25. Razonable RR, Humar A. Cytomegalovirus in solid organ transplant recipients-Guidelines of the American Society of Transplantation Infectious Diseases Community of Practice. Clin Transplant. 2019 Sep; 33 (9):e13512 Epub 2019 Mar 28
    View PubMed
  26. Valencia JCB, Abdel MP, Virk A, Osmon DR, Razonable RR. Destination Joint Spacers, Reinfection, and Antimicrobial Suppression. Clin Infect Dis. 2019 Aug 30; 69 (6):1056-1059
    View PubMed
  27. Fida M, Hamdi AM, Bryson A, Razonable RR, Abu Saleh O. Long-term Outcomes of Patients With Human Herpesvirus 6 Encephalitis. Open Forum Infect Dis. 2019 Jul; 6 (7):ofz269 Epub 2019 June 05
    View PubMed
  28. Pennington KM, Yost KJ, Escalante P, Razonable RR, Kennedy CC. Antifungal prophylaxis in lung transplant: A survey of United States' transplant centers. Clin Transplant. 2019 Jul; 33 (7):e13630 Epub 2019 June 23
    View PubMed
  29. Anderson NW, Muehlenbachs A, Arif S, Bruminhent J, Deziel PJ, Razonable RR, Wilhelm MP, Metcalfe MG, Qvarnstrom Y, Pritt BS. A Fatal Case of Disseminated Microsporidiosis Due to Anncaliia algerae in a Renal and Pancreas Allograft Recipient. Open Forum Infect Dis. 2019 Jul; 6 (7):ofz285 Epub 2019 July 08
    View PubMed
  30. Pennington KM, Razonable RR, Peters S, Scott JP, Wylam M, Daly RC, Kennedy CC. Why do lung transplant patients discontinue triazole prophylaxis? Transpl Infect Dis. 2019 Jun; 21 (3):e13067 Epub 2019 Mar 27
    View PubMed
  31. Chemaly RF, Chou S, Einsele H, Griffiths P, Avery R, Razonable RR, Mullane KM, Kotton C, Lundgren J, Komatsu TE, Lischka P, Josephson F, Douglas CM, Umeh O, Miller V, Ljungman P, Resistant Definitions Working Group of the Cytomegalovirus Drug Development Forum. Definitions of Resistant and Refractory Cytomegalovirus Infection and Disease in Transplant Recipients for Use in Clinical Trials. Clin Infect Dis. 2019 Apr 8; 68 (8):1420-1426
    View PubMed
  32. Meesing A, Abraham RS, Razonable RR. Clinical Correlation of Cytomegalovirus Infection With CMV-specific CD8+ T-cell Immune Competence Score and Lymphocyte Subsets in Solid Organ Transplant Recipients. Transplantation. 2019 Apr; 103 (4):832-838
    View PubMed
  33. Ritchie BM, Barreto JN, Barreto EF, Crow SA, Dierkhising RA, Jannetto PJ, Tosh PK, Razonable RR. Relationship of Ganciclovir Therapeutic Drug Monitoring with Clinical Efficacy and Patient Safety. Antimicrob Agents Chemother. 2019 Mar; 63 (3) Epub 2019 Feb 26
    View PubMed
  34. Beam E, Razonable RR. A survey of infection prevention and control practices among solid organ transplantation centers. Am J Infect Control. 2019 Jan; 47 (1):101-104 Epub 2018 Oct 05
    View PubMed
  35. Razonable RR, Amer H, Mardini S. Application of a New Paradigm for Cytomegalovirus Disease Prevention in Mayo Clinic's First Face Transplant. Mayo Clin Proc. 2019 Jan; 94 (1):166-170
    View PubMed
  36. El Helou G, Razonable RR. Letermovir for the prevention of cytomegalovirus infection and disease in transplant recipients: an evidence-based review. Infect Drug Resist. 2019; 12:1481-1491 Epub 2019 June 04
    View PubMed
  37. Laub MR, Crow SA, Personett HA, Dierkhising R, Boilson B, Razonable R. Effects of clotrimazole troches on tacrolimus dosing in heart transplant recipients. Transpl Infect Dis. 2018 Dec; 20 (6):e12979 Epub 2018 Sept 03
    View PubMed
  38. Abad CLR, Razonable RR. An update on Mycobacterium tuberculosis infection after hematopoietic stem cell transplantation in adults. Clin Transplant. 2018 Dec; 32 (12):e13430 Epub 2018 Nov 11
    View PubMed
  39. Abad CLR, Razonable RR. Donor derived Mycobacterium tuberculosis infection after solid-organ transplantation: A comprehensive review. Transpl Infect Dis. 2018 Oct; 20 (5):e12971 Epub 2018 Aug 12
    View PubMed
  40. Meesing A, Razonable RR. Absolute Lymphocyte Count Thresholds: A Simple, Readily Available Tool to Predict the Risk of Cytomegalovirus Infection After Transplantation. Open Forum Infect Dis. 2018 Oct; 5 (10):ofy230 Epub 2018 Sept 11
    View PubMed
  41. Razonable RR. Role of letermovir for prevention of cytomegalovirus infection after allogeneic haematopoietic stem cell transplantation. Curr Opin Infect Dis. 2018 Aug; 31 (4):286-291
    View PubMed
  42. Meesing A, Razonable RR. Pharmacologic and immunologic management of cytomegalovirus infection after solid organ and hematopoietic stem cell transplantation. Expert Rev Clin Pharmacol. 2018 Aug; 11 (8):773-788 Epub 2018 July 26
    View PubMed
  43. Razonable RR. Drug-resistant cytomegalovirus: clinical implications of specific mutations. Curr Opin Organ Transplant. 2018 Aug; 23 (4):388-394
    View PubMed
  44. Meesing A, Razonable RR. New Developments in the Management of Cytomegalovirus Infection After Transplantation. Drugs. 2018 Jul; 78 (11):1085-1103
    View PubMed
  45. Deziel PJ, Razonable R. Anti-infective chemoprophylaxis after solid-organ transplantation. Expert Rev Clin Immunol. 2018 Jun; 14 (6):469-479 Epub 2018 June 06
    View PubMed
  46. Abad CLR, Razonable RR. Mycobacterium tuberculosis after solid organ transplantation: A review of more than 2000 cases. Clin Transplant. 2018 Jun; 32 (6):e13259 Epub 2018 May 07
    View PubMed
  47. Phan TL, Lautenschlager I, Razonable RR, Munoz FM. HHV-6 in liver transplantation: A literature review. Liver Int. 2018 Feb; 38 (2):210-223 Epub 2017 July 29
    View PubMed
  48. Wieruszewski PM, Vijayvargiya P, Wilhelm MP, Razonable RR. Cytomegaloviraemia clearance with foscarnet during renal replacement therapy. J Antimicrob Chemother. 2018 Feb 1; 73 (2):548-549
    View PubMed
  49. Beeching NJ, Carratala J, Razonable RR, Oriol I, Vilela EG. Traveler's Diarrhea Recommendations for Solid Organ Transplant Recipients and Donors. Transplantation. 2018 Feb; 102 (2S Suppl 2):S35-S41
    View PubMed
  50. Beam E, Germer JJ, Lahr B, Yao JDC, Limper AH, Binnicker MJ, Razonable RR. Cytomegalovirus (CMV) DNA quantification in bronchoalveolar lavage fluid of immunocompromised patients with CMV pneumonia. Clin Transplant. 2018 Jan; 32 (1) Epub 2017 Dec 08
    View PubMed
  51. Tariq R, Pardi DS, Tosh PK, Walker RC, Razonable RR, Khanna S. Fecal Microbiota Transplantation for Recurrent Clostridium difficile Infection Reduces Recurrent Urinary Tract Infection Frequency. Clin Infect Dis. 2017 Oct 30; 65 (10):1745-1747
    View PubMed
  52. Kennedy CC, Razonable RR. Fungal Infections After Lung Transplantation. Clin Chest Med. 2017 Sep; 38 (3):511-520 Epub 2017 May 20
    View PubMed
  53. Razonable RR. Progress Toward HHV-8 Prevention After Transplantation: In Search for Optimal Diagnostic Strategies. Transplantation 2017 Aug; 101 (8):1751-1752
    View PubMed
  54. Ramanan P, Cummins NW, Wilhelm MP, Heimbach JK, Dierkhising R, Kremers WK, Rosen CB, Gores GJ, Razonable RR. Epidemiology, risk factors, and outcomes of infections in patients undergoing liver transplantation for hilar cholangiocarcinoma. Clin Transplant. 2017 Aug; 31 (8) Epub 2017 July 05
    View PubMed
  55. Ramanan P, Razonable RR. Evaluation of COBAS AmpliPrep/COBAS TaqMan CMV Test for use in hematopoietic stem cell transplant recipients. Expert Rev Mol Diagn. 2017 Jul; 17 (7):633-639 Epub 2017 May 15
    View PubMed
  56. Bruminhent J, Cawcutt KA, Thongprayoon C, Petterson TM, Kremers WK, Razonable RR. Epidemiology, risk factors, and outcome of Clostridium difficile infection in heart and heart-lung transplant recipients. Clin Transplant. 2017 Jun; 31 (6) Epub 2017 Apr 17
    View PubMed
  57. Dioverti MV, Lahr BD, Germer JJ, Yao JD, Gartner ML, Razonable RR. Comparison of Standardized Cytomegalovirus (CMV) Viral Load Thresholds in Whole Blood and Plasma of Solid Organ and Hematopoietic Stem Cell Transplant Recipients with CMV Infection and Disease. Open Forum Infect Dis. 2017 Summer; 4 (3):ofx143 Epub 2017 July 08
    View PubMed
  58. Singh N, Sifri CD, Silveira FP, Miller R, Gregg KS, Huprikar S, Lease ED, Zimmer A, Dummer JS, Spak CW, Koval C, Banach DB, Shroff M, Le J, Ostrander D, Avery R, Eid A, Razonable RR, Montero J, Blumberg E, Alynbiawi A, Morris MI, Randall HB, Alangaden G, Tessier J, Cacciarelli TV, Wagener MM, Sun HY. Unique characteristics of cryptococcosis identified after death in patients with liver cirrhosis: comparison with concurrent cohort diagnosed antemortem. Med Mycol. 2017 Apr 1; 55 (3):278-284
    View PubMed
  59. Abad CL, Lahr BD, Razonable RR. Epidemiology and risk factors for infection after living donor liver transplantation. Liver Transpl. 2017 Apr; 23 (4):465-477
    View PubMed
  60. Vergidis P, Ariza-Heredia EJ, Nellore A, Kotton CN, Kaul DR, Morris MI, Kelesidis T, Shah H, Park SY, Nguyen MH, Razonable RR. Rhodococcus Infection in Solid Organ and Hematopoietic Stem Cell Transplant Recipients1. Emerg Infect Dis. 2017 Mar; 23: (3)510-512.
    View PubMed
  61. Abad CL, Razonable RR. Treatment of alpha and beta herpesvirus infections in solid organ transplant recipients. Expert Rev Anti Infect Ther. 2017 Feb; 15 (2):93-110 Epub 2016 Dec 12
    View PubMed
  62. Aburjania N, Abu Saleh OM, Razonable RR. How do we treat human herpesvirus 6 infection after allogeneic hematopoietic stem cell transplantation? Future Virology. 2017; 12(3):85-8. Epub 1900 Jan 01.
  63. Ljungman P, Boeckh M, Hirsch HH, Josephson F, Lundgren J, Nichols G, Pikis A, Razonable RR, Miller V, Griffiths PD, Disease Definitions Working Group of the Cytomegalovirus Drug Development Forum. Definitions of Cytomegalovirus Infection and Disease in Transplant Patients for Use in Clinical Trials. Clin Infect Dis. 2017 Jan 1; 64 (1):87-91 Epub 2016 Sept 28
    View PubMed
  64. Hefazi M, Damlaj M, Alkhateeb HB, Partain DK, Patel R, Razonable RR, Gastineau DA, Al-Kali A, Hashmi SK, Hogan WJ, Litzow MR, Patnaik MM. Vancomycin-resistant Enterococcus colonization and bloodstream infection: prevalence, risk factors, and the impact on early outcomes after allogeneic hematopoietic cell transplantation in patients with acute myeloid leukemia. Transpl Infect Dis. 2016 Dec; 18 (6):913-920 Epub 2016 Nov 11
    View PubMed
  65. Tyner HL, Virk A, Nassr A, Razonable R. Mycoplasma hominis vertebral spine infection: Case report and a review of infections of bone and joints. J Infect Chemother. 2016 Nov; 22: (11)755-758.
    View PubMed
  66. Abad CL, Razonable RR. alpha Herpes Virus Infections Among Renal Transplant Recipients. Semin Nephrol. 2016 Sep; 36 (5):344-350
    View PubMed
  67. Razonable RR. Not the Usual Viral Suspects: Parvovirus B19, West Nile Virus, and Human T-Cell Lymphotrophic Virus Infections After Kidney Transplantation. Semin Nephrol. 2016 Sep; 36 (5):428-434
    View PubMed
  68. Dioverti MV, Razonable RR. Cytomegalovirus. Microbiol Spectr. 2016 Aug; 4 (4)
    View PubMed
  69. Abad CL, Razonable RR. Non-tuberculous mycobacterial infections in solid organ transplant recipients: An update. J Clin Tuberc Other Mycobact Dis. 2016 Aug; 4:1-8 Epub 2016 Apr 27
    View PubMed
  70. Pinto GG, Poloni JA, Rotta LN, Razonable RR, Pasqualotto AC. Screening for BK virus nephropathy in kidney transplant recipients: comparison of diagnostic tests. J Bras Nefrol. 2016 Jul-Sep; 38 (3):356-362
    View PubMed
  71. Beaird OE, Freifeld A, Ison MG, Lawrence SJ, Theodoropoulos N, Clark NM, Razonable RR, Alangaden G, Miller R, Smith J, Young JA, Hawkinson D, Pursell K, Kaul DR. Current practices for treatment of respiratory syncytial virus and other non-influenza respiratory viruses in high-risk patient populations: a survey of institutions in the Midwestern Respiratory Virus Collaborative. Transpl Infect Dis. 2016 Apr; 18 (2):210-5 Epub 2016 Mar 29
    View PubMed
  72. Beam E, Lesnick T, Kremers W, Kennedy CC, Razonable RR. Cytomegalovirus disease is associated with higher all-cause mortality after lung transplantation despite extended antiviral prophylaxis. Clin Transplant. 2016 Mar; 30 (3):270-8 Epub 2016 Mar 01
    View PubMed
  73. Beam E, Keating MR, Razonable RR. A Survey of Infection Prevention and Control Practices among Hematopoietic Stem Cell Transplant Centers. Infect Control Hosp Epidemiol. 2016 Mar; 37: (3)348-51.
    View PubMed
  74. Dioverti MV, Lahr B, Razonable RR. Treatment of cytomegalovirus infection and disease pre- and post-quantitative nucleic acid test standardization: does use of a more sensitive assay lead to longer treatment duration? Clin Transplant. 2016 Feb; 30: (2)154-60.
    View PubMed
  75. Dioverti MV, Razonable RR. Cytomegalovirus Microbiology Spectrum. 2016; 4: (4)DMIH2-0022-2015.
  76. Singh N, Sifri CD, Silveira FP, Miller R, Gregg KS, Huprikar S, Lease ED, Zimmer A, Dummer JS, Spak CW, Koval C, Banach DB, Shroff M, Le J, Ostrander D, Avery R, Eid A, Razonable RR, Montero J, Blumberg E, Alynbiawi A, Morris MI, Randall HB, Alangaden G, Tessier J, Wagener MM, Sun HY. Cryptococcosis in Patients With Cirrhosis of the Liver and Posttransplant Outcomes. Transplantation. 2015 Oct; 99: (10)2132-41.
    View PubMed
  77. Dioverti MV, Razonable RR. Clinical utility of cytomegalovirus viral load in solid organ transplant recipients. Curr Opin Infect Dis. 2015 Aug; 28 (4):317-22
    View PubMed
  78. Chong PP, Kennedy CC, Hathcock MA, Kremers WK, Razonable RR. Epidemiology of invasive fungal infections in lung transplant recipients on long-term azole antifungal prophylaxis. Clin Transplant. 2015 Apr; 29(4):311-8. Epub 2015 Feb 12.
    View PubMed
  79. Bruminhent J, Thongprayoon C, Dierkhising RA, Kremers WK, Theel ES, Razonable RR. Risk factors for cytomegalovirus reactivation after liver transplantation: can pre-transplant cytomegalovirus antibody titers predict outcome? Liver Transpl. 2015 Apr; 21: (4)539-46.
    View PubMed
  80. Melendez DP, Razonable RR. Letermovir and inhibitors of the terminase complex: a promising new class of investigational antiviral drugs against human cytomegalovirus. Infect Drug Resist. 2015; 8:269-77 Epub 2015 Aug 05
    View PubMed
  81. Sun HY, Alexander BD, Huprikar S, Forrest GN, Bruno D, Lyon GM, Wray D, Johnson LB, Sifri CD, Razonable RR, Morris MI, Stosor V, Wagener MM, Singh N. Predictors of immune reconstitution syndrome in organ transplant recipients with cryptococcosis: implications for the management of immunosuppression. Clin Infect Dis. 2015 Jan 1; 60 (1):36-44 Epub 2014 Sept 09
    View PubMed
  82. Ramanan P, Deziel PJ, Norby SM, Yao JD, Garza I, Razonable RR. Donor-transmitted HTLV-1-associated myelopathy in a kidney transplant recipient--case report and literature review. Am J Transplant. 2014 Oct; 14(10):2417-21. Epub 2014 Aug 19.
    View PubMed
  83. Bruminhent J, Deziel PJ, Wotton JT, Binnicker MJ, Razonable RR. Prolonged shedding of pandemic influenza A (H1N1) 2009 virus in a pancreas-after-kidney transplant recipient. J Clin Virol. 2014 Oct; 61(2):302-4. Epub 2014 Jul 16.
    View PubMed
  84. Bruminhent J, Razonable RR. Outcomes of patients with cytomegalovirus viremia at the time of liver transplantation. Liver Transpl. 2014 Sep; 20(9):1029-33. Epub 2014 Aug 04.
    View PubMed
  85. Beam E, Dioverti V, Razonable RR. Emerging cytomegalovirus management strategies after solid organ transplantation: challenges and opportunities. Curr Infect Dis Rep. 2014 Sep; 16 (9):419
    View PubMed
  86. Melendez D, Razonable RR. Immune-based monitoring for cytomegalovirus infection in solid organ transplantation: is it ready for clinical primetime? Expert Rev Clin Immunol. 2014 Sep; 10(9):1213-27. Epub 2014 Jul 31.
    View PubMed
  87. Marcelin JR, Beam E, Razonable RR. Cytomegalovirus infection in liver transplant recipients: updates on clinical management. World J Gastroenterol. 2014 Aug 21; 20 (31):10658-67
    View PubMed
  88. Khare R, Gupta S, Arif S, Jentoft ME, Deziel PJ, Roden AC, Wilhelm MP, Razonable RR, Wengenack NL. Misidentification of Neosartorya pseudofischeri as Aspergillus fumigatus in a lung transplant patient. J Clin Microbiol. 2014 Jul; 52 (7):2722-5 Epub 2014 May 14
    View PubMed
  89. Bruminhent J, Razonable RR. Management of cytomegalovirus infection and disease in liver transplant recipients. World J Hepatol. 2014 Jun 27; 6 (6):370-83
    View PubMed
  90. Ariza-Heredia EJ, Beam EN, Lesnick TG, Cosio FG, Kremers WK, Razonable RR. Impact of urinary tract infection on allograft function after kidney transplantation. Clin Transplant. 2014 Jun; 28(6):683-90. Epub 2014 Apr 27.
    View PubMed
  91. Vergidis P, Razonable RR, Wheat LJ, Estes L, Caliendo AM, Baden LR, Wingard JR, Baddley J, Assi M, Norris S, Chandrasekar P, Shields R, Nguyen H, Freifeld A, Kohler R, Kleiman M, Walsh TJ, Hage CA. Reduction in false-positive Aspergillus serum galactomannan enzyme immunoassay results associated with use of piperacillin-tazobactam in the United States. J Clin Microbiol. 2014 Jun; 52 (6):2199-201 Epub 2014 Apr 09
    View PubMed
  92. Ramanan P, Deziel PJ, Razonable RR. Rhodococcus globerulus bacteremia in an allogeneic hematopoietic stem cell transplant recipient: report of the first transplant case and review of the literature. Transpl Infect Dis. 2014 Jun; 16(3):484-9. Epub 2014 May 02.
    View PubMed
  93. Marcelin JR, Wilson JW, Razonable RR, Mayo Clinic Hematology/Oncology and Transplant Infectious Diseases Services. Oral ribavirin therapy for respiratory syncytial virus infections in moderately to severely immunocompromised patients. Transpl Infect Dis. 2014 Apr; 16: (2)242-50.
    View PubMed
  94. Dave M, Purohit T, Razonable R, Loftus EV Jr. Opportunistic infections due to inflammatory bowel disease therapy. Inflamm Bowel Dis. 2014 Jan; 20 (1):196-212
    View PubMed
  95. Bruminhent J, Razonable RR. Management of Cytomegalovirus Infection and Disease in Liver Transplant Recipients. World Journal of Hepatology.2014;6:(6):370-83.
  96. Ramanan P, Razonable RR. Elizabethkingia species sepsis after lung transplantation: case report and literature review. Transpl Infect Dis. 2013 Dec; 15(6):E229-34. Epub 2013 Oct 14.
    View PubMed
  97. Razonable RR, Hayden RT. Clinical utility of viral load in management of cytomegalovirus infection after solid organ transplantation. Clin Microbiol Rev. 2013 Oct; 26 (4):703-27
    View PubMed
  98. Reid G, Huprikar S, Patel G, Razonable RR, Mossad S, Levi M, Gregg K, Shoham S, Humar A, Adams W, Kumar D. A multicenter evaluation of pandemic influenza A/H1N1 in hematopoietic stem cell transplant recipients. Transpl Infect Dis. 2013 Oct; 15(5):487-92. Epub 2013 Jul 25.
    View PubMed
  99. Ramanan P, Razonable RR. Cytomegalovirus infections in solid organ transplantation: a review. Infect Chemother. 2013 Sep; 45 (3):260-71 Epub 2013 Sept 27
    View PubMed
  100. Chong PP, Razonable RR. Diagnostic and management strategies for donor-derived infections. Infect Dis Clin North Am. 2013 Jun; 27(2):253-70. Epub 2013 Mar 26.
    View PubMed
  101. Razonable RR. Management strategies for cytomegalovirus infection and disease in solid organ transplant recipients. Infect Dis Clin North Am. 2013 Jun; 27 (2):317-42 Epub 2013 Mar 26
    View PubMed
  102. Razonable RR, Asberg A, Rollag H, Duncan J, Boisvert D, Yao JD, Caliendo AM, Humar A, Do TD. Virologic suppression measured by a cytomegalovirus (CMV) DNA test calibrated to the World Health Organization international standard is predictive of CMV disease resolution in transplant recipients. Clin Infect Dis. 2013 Jun; 56 (11):1546-53 Epub 2013 Feb 15
    View PubMed
  103. Lee SO, Brown RA, Razonable RR. Association between a functional polymorphism in Toll-like receptor 3 and chronic hepatitis C in liver transplant recipients. Transpl Infect Dis. 2013 Apr; 15(2):111-9. Epub 2012 Dec 13.
    View PubMed
  104. Razonable RR, Humar A, AST Infectious Diseases Community of Practice. Cytomegalovirus in solid organ transplantation. Am J Transplant. 2013 Mar; 13 Suppl 4:93-106.
    View PubMed
  105. Razonable RR. Human herpesviruses 6, 7 and 8 in solid organ transplant recipients. Am J Transplant. 2013 Feb; 13 Suppl 3:67-77; quiz 77-8.
    View PubMed
  106. Ariza-Heredia EJ, Beam EN, Lesnick TG, Kremers WK, Cosio FG, Razonable RR. Urinary tract infections in kidney transplant recipients: role of gender, urologic abnormalities, and antimicrobial prophylaxis. Ann Transplant. 2013; 18: 195-204.
    View PubMed
  107. Beam E, Razonable RR. Cytomegalovirus in solid organ transplantation: epidemiology, prevention, and treatment. Curr Infect Dis Rep. 2012 Dec; 14 (6):633-41
    View PubMed
  108. Vergidis P, Lesnick TG, Kremers WK, Razonable RR. Prosthetic joint infection in solid organ transplant recipients: a retrospective case-control study. Transpl Infect Dis. 2012 Aug; 14 (4):380-6 Epub 2012 Jan 20
    View PubMed
  109. Lee SO, Brown RA, Razonable RR. Chromosomally integrated human herpesvirus-6 in transplant recipients. Transpl Infect Dis. 2012 Aug; 14(4):346-54. Epub 2012 Feb 09.
    View PubMed
  110. Ariza-Heredia EJ, Patel R, Blumberg EA, Walker RC, Lewis R, Evans J, Sankar A, Willliams MD, Rogers J, Milano C, Razonable RR. Outcomes of transplantation using organs from a donor infected with Klebsiella pneumoniae carbapenemase (KPC)-producing K. pneumoniae. Transpl Infect Dis. 2012 Jun; 14(3):229-36. Epub 2012 May 25.
    View PubMed
  111. Tapia GG, Razonable RR, Eckel-Passow JE, Lahr BD, Afessa B, Keegan MT, Catania J, Baddour LM. A scoring model of factors associated with Candida glabrata candidemia among critically ill patients. Mycoses. 2012 May; 55(3):228-36. Epub 2011 Jul 21.
    View PubMed
  112. Lautenschlager I, Razonable RR. Human herpesvirus-6 infections in kidney, liver, lung, and heart transplantation: review. Transpl Int. 2012 May; 25(5):493-502. Epub 2012 Feb 23.
    View PubMed
  113. Watkins RR, Lemonovich TL, Razonable RR. Immune response to CMV in solid organ transplant recipients: current concepts and future directions. Expert Rev Clin Immunol. 2012 May; 8(4):383-93.
    View PubMed
  114. Pellett PE, Ablashi DV, Ambros PF, Agut H, Caserta MT, Descamps V, Flamand L, Gautheret-Dejean A, Hall CB, Kamble RT, Kuehl U, Lassner D, Lautenschlager I, Loomis KS, Luppi M, Lusso P, Medveczky PG, Montoya JG, Mori Y, Ogata M, Pritchett JC, Rogez S, Seto E, Ward KN, Yoshikawa T, Razonable RR. Chromosomally integrated human herpesvirus 6: questions and answers. Rev Med Virol. 2012 May; 22(3):144-55. Epub 2011 Nov 04.
    View PubMed
  115. Grossi PA, Costa AN, Fehily D, Blumberg EA, Kuehnert MJ, Fishman JA, Ison MG, Lattes R, Kotton CN, Lilleri D, Kabanova A, Lanzavecchia A, Gerna G, Razonable RR, Comoli P, Zecca M, Basso S, Ginevri F, Grossi A, Schena FP, Rimola A, Burra P, De Martin E, Rodriguez-Castro KI, Fagiuoli S, Pasulo L, Bruno R, Andreone P, Loggi E, Arena F, Maria Rossolini G, Sganga G, Cozza V. Infections and organ transplantation: new challenges for prevention and treatment--a colloquium. Transplantation. 2012 Mar 15; 93(5 Suppl):S4-S39.
    View PubMed
  116. Kang SH, Abdel-Massih RC, Brown RA, Dierkhising RA, Kremers WK, Razonable RR. Homozygosity for the toll-like receptor 2 R753Q single-nucleotide polymorphism is a risk factor for cytomegalovirus disease after liver transplantation. J Infect Dis. 2012 Feb 15; 205 (4):639-46 Epub 2012 Jan 04
    View PubMed
  117. Ariza-Heredia E, Razonable RR. Incidental hepatic schistosomiasis in a liver transplant recipient. Transpl Infect Dis. 2012 Feb; 14(1):75-8. Epub 2011 Apr 19.
    View PubMed
  118. Ariza-Heredia EJ, Fishman JE, Cleary T, Smith L, Razonable RR, Abbo L. Clinical and radiological features of respiratory syncytial virus in solid organ transplant recipients: a single-center experience. Transpl Infect Dis. 2012 Feb; 14: (1)64-71.
    View PubMed
  119. Winston DJ Saliba F Blumberg E Abouljoud M Garcia-Diaz JB Goss JA Clough L Avery R Limaye AP Ericzon BG Navasa M Troisi RI Chen H Villano SA Uknis ME, 1263-301 Clinical Study Group (including Razonable RR). Efficacy and safety of maribavir dosed at 100 mg orally twice daily for the prevention of cytomegalovirus disease in liver transplant recipients: a randomized, double-blind, multicenter controlled trial. Amerian Journal of Transplantation. 2012; 12(11):3021-30.
  120. Ariza-Heredia EJ, Dababneh AS, Wilhelm MP, Wengenack NL, Razonable RR, Wilson JW. Mycobacterium wolinskyi: a case series and review of the literature. Diagn Microbiol Infect Dis. 2011 Dec; 71(4):421-7. Epub 2011 Sep 25.
    View PubMed
  121. Razonable RR. Rare, unusual, and less common virus infections after organ transplantation. Curr Opin Organ Transplant. 2011 Dec; 16(6):580-7.
    View PubMed
  122. Parsaik AK, Bhalla T, Dong M, Rostambeigi N, Dierkhising RA, Dean P, Abraham R, Prieto M, Kremers WK, Razonable RR, Kudva YC. Epidemiology of cytomegalovirus infection after pancreas transplantation. Transplantation. 2011 Nov 15; 92(9):1044-50.
    View PubMed
  123. Ariza-Heredia EJ, Razonable RR. Human herpes virus 8 in solid organ transplantation. Transplantation. 2011 Oct 27; 92 (8):837-44
    View PubMed
  124. Razonable RR. Antiviral drugs for viruses other than human immunodeficiency virus. Mayo Clin Proc. 2011 Oct; 86 (10):1009-26
    View PubMed
  125. Lee SO, Brown RA, Kang SH, Abdel Massih RC, Razonable RR. Toll-like receptor 4 polymorphisms and the risk of gram-negative bacterial infections after liver transplantation. Transplantation. 2011 Sep 27; 92(6):690-6.
    View PubMed
  126. Lee SO, Brown RA, Kang SH, Abdel-Massih RC, Razonable RR. Toll-like receptor 2 polymorphism and Gram-positive bacterial infections after liver transplantation. Liver Transpl. 2011 Sep; 17(9):1081-8.
    View PubMed
  127. Romero FA, Deziel PJ, Razonable RR. Majocchi's granuloma in solid organ transplant recipients. Transpl Infect Dis. 2011 Aug; 13(4):424-32. Epub 2011 Jan 27.
    View PubMed
  128. Lee SO, Brown RA, Razonable RR. Clinical significance of pretransplant chromosomally integrated human herpesvirus-6 in liver transplant recipients. Transplantation. 2011 Jul 27; 92(2):224-9.
    View PubMed
  129. El Helou OC, Berbari EF, Lahr BD, Marculescu CE, Razonable RR, Steckelberg JM, Hanssen AD, Osmon DR. Management of prosthetic joint infection treated with two-stage exchange: the impact of antimicrobial therapy duration. Curr. Orthop. Pract. 2011 Jul-Aug; 22(4):333-8.
  130. Lee SO, Brown RA, Eid AJ, Razonable RR. Chromosomally integrated human herpesvirus-6 in kidney transplant recipients. Nephrol Dial Transplant. 2011 Jul; 26(7):2391-3. Epub 2011 May 12.
    View PubMed
  131. Al-Hasan MN, Razonable RR, Kremers WK, Baddour LM. Impact of Gram-negative bloodstream infection on long-term allograft survival after kidney transplantation. Transplantation. 2011 Jun 15; 91(11):1206-10.
    View PubMed
  132. Razonable RR. Management of viral infections in solid organ transplant recipients. Expert Rev Anti Infect Ther. 2011 Jun; 9(6):685-700.
    View PubMed
  133. Lee SO, Kang SH, Abdel-Massih RC, Brown RA, Razonable RR. Spectrum of early-onset and late-onset bacteremias after liver transplantation: implications for management. Liver Transpl. 2011 Jun; 17 (6):733-41
    View PubMed
  134. Razonable RR, Findlay JY, O'Riordan A, Burroughs SG, Ghobrial RM, Agarwal B, Davenport A, Gropper M. Critical care issues in patients after liver transplantation. Liver Transpl. 2011 May; 17(5):511-27.
    View PubMed
  135. Romero FA, Razonable RR. Infections in liver transplant recipients. World J Hepatol. 2011 Apr 27; 3 (4):83-92
    View PubMed
  136. Wermers RA, Cooper K, Razonable RR, Deziel PJ, Whitford GM, Kremers WK, Moyer TP. Fluoride excess and periostitis in transplant patients receiving long-term voriconazole therapy. Clin Infect Dis. 2011 Mar 1; 52(5):604-11. Epub 2011 Jan 16.
    View PubMed
  137. Hebart H, Lengerke C, Ljungman P, Paya CV, Klingebiel T, Loeffler J, Pfaffenrath S, Lewensohn-Fuchs I, Barkholt L, Tomiuk J, Meisner C, Lunenberg J, Top B, Razonable RR, Patel R, Litzow MR, Jahn G, Einsele H. Prospective comparison of PCR-based vs late mRNA-based preemptive antiviral therapy for HCMV infection in patients after allo-SCT. Bone Marrow Transplant. 2011 Mar; 46(3):408-15. Epub 2010 Jun 28.
    View PubMed
  138. Ariza-Heredia E, Razonable RR. HHV-8 in solid organ transplantation. Transplantation .2011;27:(92):837-44.
  139. El-Helou O, Berbari EF, Brown RA, Gralewski JH, Osmon DR, Razonable RR. Functional assessment of Toll-like receptor 2 and its relevance in patients with Staphylococcus aureus infection of joint prosthesis. Hum Immunol. 2011 Jan; 72(1):47-53. Epub 2010 Oct 28.
    View PubMed
  140. Razonable RR. Infections due to human herpesvirus 6 in solid organ transplant recipients. Curr Opin Organ Transplant. 2010 Dec; 15 (6):671-5
    View PubMed
  141. Sun HY, Alexander BD, Lortholary O, Dromer F, Forrest GN, Lyon GM, Somani J, Gupta KL, del Busto R, Pruett TL, Sifri CD, Limaye AP, John GT, Klintmalm GB, Pursell K, Stosor V, Morris MI, Dowdy LA, Munoz P, Kalil AC, Garcia-Diaz J, Orloff SL, House AA, Houston SH, Wray D, Huprikar S, Johnson LB, Humar A, Razonable RR, Fisher RA, Husain S, Wagener MM, Singh N, Cryptococcal Collaborative Transplant Study Group. Unrecognized pretransplant and donor-derived cryptococcal disease in organ transplant recipients. Clin Infect Dis. 2010 Nov 1; 51(9):1062-9.
    View PubMed
  142. Osawa R, Alexander BD, Forrest GN, Lyon GM, Somani J, del Busto R, Pruett TL, Sifri CD, Limaye AP, Klintmalm GB, Pursell K, Stosor V, Morris MI, Dowdy LA, Kalil AC, Garcia-Diaz J, Orloff SL, Houston SH, Wray D, Huprikar S, Johnson LB, Razonable RR, Fisher RA, Wagener MM, Husain S, Singh N. Geographic differences in disease expression of cryptococcosis in solid organ transplant recipients in the United States. Ann Transplant. 2010 Oct-Dec; 15(4):77-83.
    View PubMed
  143. Lee SO, Razonable RR. Current concepts on cytomegalovirus infection after liver transplantation. World J Hepatol. 2010 Sep 27; 2 (9):325-36
    View PubMed
  144. Razonable RR, Lautenschlager I. Impact of human herpes virus 6 in liver transplantation. World J Hepatol. 2010 Sep 27; 2 (9):345-53
    View PubMed
  145. Boucher H, Miller LG, Razonable RR. Serious infections caused by methicillin-resistant Staphylococcus aureus. Clin Infect Dis. 2010 Sep 15; 51 Suppl 2:S183-97.
    View PubMed
  146. Sun HY, Alexander BD, Lortholary O, Dromer F, Forrest GN, Lyon GM, Somani J, Gupta KL, Del Busto R, Pruett TL, Sifri CD, Limaye AP, John GT, Klintmalm GB, Pursell K, Stosor V, Morris MI, Dowdy LA, Munoz P, Kalil AC, Garcia-Diaz J, Orloff SL, House AA, Houston SH, Wray D, Huprikar S, Johnson LB, Humar A, Razonable RR, Fisher RA, Husain S, Wagener MM, Singh N, Cryptococcal Collaborative Transplant Study Group. Cutaneous cryptococcosis in solid organ transplant recipients. Med Mycol. 2010 Sep; 48(6):785-91.
    View PubMed
  147. Razonable RR. Strategies for managing cytomegalovirus in transplant recipients. Expert Opin Pharmacother. 2010 Aug; 11(12):1983-97.
    View PubMed
  148. El Helou OC, Berbari EF, Lahr BD, Eckel-Passow JE, Razonable RR, Sia IG, Virk A, Walker RC, Steckelberg JM, Wilson WR, Hanssen AD, Osmon DR. Efficacy and safety of rifampin containing regimen for staphylococcal prosthetic joint infections treated with debridement and retention. Eur J Clin Microbiol Infect Dis. 2010 Aug; 29 (8):961-7 Epub 2010 May 27
    View PubMed
  149. Kumar D, Michaels MG, Morris MI, Green M, Avery RK, Liu C, Danziger-Isakov L, Stosor V, Estabrook M, Gantt S, Marr KA, Martin S, Silveira FP, Razonable RR, Allen UD, Levi ME, Lyon GM, Bell LE, Huprikar S, Patel G, Gregg KS, Pursell K, Helmersen D, Julian KG, Shiley K, Bono B, Dharnidharka VR, Alavi G, Kalpoe JS, Shoham S, Reid GE, Humar A, American Society of Transplantation H1N1 Collaborative Study Group. Outcomes from pandemic influenza A H1N1 infection in recipients of solid-organ transplants: a multicentre cohort study. Lancet Infect Dis. 2010 Aug; 10(8):521-6. Epub 2010 Jul 09.
    View PubMed
  150. Brown RA, Razonable RR. A real-time PCR assay for the simultaneous detection of functional N284I and L412F polymorphisms in the human Toll-like receptor 3 gene. J Mol Diagn. 2010 Jul; 12 (4):493-7 Epub 2010 Apr 22
    View PubMed
  151. Boyce RD, Deziel PJ, Otley CC, Wilhelm MP, Eid AJ, Wengenack NL, Razonable RR. Phaeohyphomycosis due to Alternaria species in transplant recipients. Transpl Infect Dis. 2010 Jun; 12 (3):242-50 Epub 2009 Dec 09
    View PubMed
  152. Eid AJ, Razonable RR. New developments in the management of cytomegalovirus infection after solid organ transplantation. Drugs. 2010 May 28; 70(8):965-81.
    View PubMed
  153. Arthurs SK, Eid AJ, Deziel PJ, Marshall WF, Cassivi SD, Walker RC, Razonable RR. The impact of invasive fungal diseases on survival after lung transplantation. Clin Transplant. 2010 May-Jun; 24(3):341-8. Epub 2009 Aug 27.
    View PubMed
  154. Eid AJ, Brown RA, Arthurs SK, Lahr BD, Eckel-Passow JE, Larson TS, Razonable RR. A prospective longitudinal analysis of cytomegalovirus (CMV)-specific CD4+ and CD8+ T cells in kidney allograft recipients at risk of CMV infection. Transpl Int. 2010 May 1; 23(5):506-13. Epub 2009 Nov 27.
    View PubMed
  155. Brown RA, Gralewski JH, Eid AJ, Knoll BM, Finberg RW, Razonable RR. R753Q single-nucleotide polymorphism impairs toll-like receptor 2 recognition of hepatitis C virus core and nonstructural 3 proteins. Transplantation. 2010 Apr 15; 89 (7):811-5
    View PubMed
  156. Osawa R, Alexander BD, Lortholary O, Dromer F, Forrest GN, Lyon GM, Somani J, Gupta KL, Del Busto R, Pruett TL, Sifri CD, Limaye AP, John GT, Klintmalm GB, Pursell K, Stosor V, Morris MI, Dowdy LA, Munoz P, Kalil AC, Garcia-Diaz J, Orloff S, House AA, Houston S, Wray D, Huprikar S, Johnson LB, Humar A, Razonable RR, Fisher RA, Husain S, Wagener MM, Singh N. Identifying predictors of central nervous system disease in solid organ transplant recipients with cryptococcosis. Transplantation. 2010 Jan 15; 89(1):69-74.
    View PubMed
  157. Razonable RR. Immune-based therapies for cytomegalovirus infection. Immunotherapy. 2010 Jan; 2(1):117-30.
    View PubMed
  158. Eid AJ, Arthurs SK, Deziel PJ, Wilhelm MP, Razonable RR. Clinical predictors of relapse after treatment of primary gastrointestinal cytomegalovirus disease in solid organ transplant recipients. Am J Transplant. 2010 Jan; 10 (1):157-61 Epub 2009 Nov 04
    View PubMed
  159. Sun HY, Alexander BD, Lortholary O, Dromer F, Forrest GN, Lyon GM, Somani J, Gupta KL, del Busto R, Pruett TL, Sifri CD, Limaye AP, John GT, Klintmalm GB, Pursell K, Stosor V, Morris MI, Dowdy LA, Munoz P, Kalil AC, Garcia-Diaz J, Orloff S, House AA, Houston S, Wray D, Huprikar S, Johnson LB, Humar A, Razonable RR, Husain S, Singh N. Lipid formulations of amphotericin B significantly improve outcome in solid organ transplant recipients with central nervous system cryptococcosis. Clin Infect Dis. 2009 Dec 1; 49(11):1721-8.
    View PubMed
  160. Razonable RR, Eid AJ. Viral infections in transplant recipients. Minerva Med. 2009 Dec; 100(6):479-501.
    View PubMed
  161. Eid AJ, Brown RA, Hogan WJ, Lahr BD, Eckel-Passow JE, Litzow MR, Razonable RR. Kinetics of interferon-gamma producing cytomegalovirus (CMV)-specific CD4+ and CD8+ T lymphocytes and the risk of subsequent CMV viremia after allogeneic hematopoietic stem cell transplantation. Transpl Infect Dis. 2009 Dec; 11(6):519-28. Epub 2009 Sep 09.
    View PubMed
  162. Razonable RR, Zerr DM, AST Infectious Diseases Community of Practice. HHV-6, HHV-7 and HHV-8 in solid organ transplant recipients. Am J Transplant. 2009 Dec; 9 Suppl 4:S97-100.
    View PubMed
  163. Razonable RR, Zerr DM, AST Infectious Diseases Community of Practice. HHV-6, HHV-7 and HHV-8 in solid organ transplant recipients. Am J Transplant. 2009 Dec; 9 Suppl 4:S100-3.
    View PubMed
  164. Brown RA, Gralewski JH, Razonable RR. The R753Q polymorphism abrogates toll-like receptor 2 signaling in response to human cytomegalovirus. Clin Infect Dis. 2009 Nov 1; 49 (9):e96-9
    View PubMed
  165. Abdel Massih RC, Razonable RR. Human herpesvirus 6 infections after liver transplantation. World J Gastroenterol. 2009 Jun 7; 15 (21):2561-9
    View PubMed
  166. Razonable RR. Cytomegalovirus infection in solid organ transplant recipients. Johns Hopkins eTransplant ID Review.. 2009 Jun;
  167. Larson AN, Razonable RR, Hanssen AD. Capnocytophaga canimorsus a novel pathogen for joint arthroplasty. Clin Orthop Relat Res. 2009 Jun; 467 (6):1634-8 Epub 2008 Dec 09
    View PubMed
  168. Al-Hasan MN, Razonable RR, Eckel-Passow JE, Baddour LM. Incidence rate and outcome of Gram-negative bloodstream infection in solid organ transplant recipients. Am J Transplant. 2009 Apr; 9(4):835-43.
    View PubMed
  169. Cummins NW, Deziel PJ, Abraham RS, Razonable RR. Deficiency of cytomegalovirus (CMV)-specific CD8+ T cells in patients presenting with late-onset CMV disease several years after transplantation. Transpl Infect Dis. 2009 Feb; 11(1):20-7. Epub 2008 Sep 21.
    View PubMed
  170. Razonable RR. Management of cytomegalovirus infection after renal transplantation. IDCP. 2009; 17(4):220-30.
  171. Razonable RR, Pulido JS, Deziel PJ, Dev S, Salomao DR, Walker RC. Chorioretinitis and vitreitis due to Tropheryma whipplei after transplantation: case report and review. Transpl Infect Dis. 2008 Dec; 10(6):413-8. Epub 2008 Jun 18.
    View PubMed
  172. El Helou OC, Berbari EF, Marculescu CE, El Atrouni WI, Razonable RR, Steckelberg JM, Hanssen AD, Osmon DR. Outcome of enterococcal prosthetic joint infection: is combination systemic therapy superior to monotherapy? Clin Infect Dis. 2008 Oct 1; 47(7):903-9.
    View PubMed
  173. Pandian TK, Deziel PJ, Otley CC, Eid AJ, Razonable RR. Mycobacterium marinum infections in transplant recipients: case report and review of the literature. Transpl Infect Dis. 2008 Oct; 10(5):358-63. Epub 2008 May 15.
    View PubMed
  174. Arthurs SK, Eid AJ, Pedersen RA, Kremers WK, Cosio FG, Patel R, Razonable RR. Delayed-onset primary cytomegalovirus disease and the risk of allograft failure and mortality after kidney transplantation. Clin Infect Dis. 2008 Mar 15; 46 (6):840-6
    View PubMed
  175. Eid AJ, Arthurs SK, Deziel PJ, Wilhelm MP, Razonable RR. Emergence of drug-resistant cytomegalovirus in the era of valganciclovir prophylaxis: therapeutic implications and outcomes. Clin Transplant. 2008 Mar-Apr; 22 (2):162-70
    View PubMed
  176. Eid AJ, Bakri SJ, Kijpittayarit S, Razonable RR. Clinical features and outcomes of cytomegalovirus retinitis after transplantation. Transpl Infect Dis. 2008 Feb; 10(1):13-8. Epub 2007 May 19.
    View PubMed
  177. Eid AJ, Paya CV, Razonable RR. Optimal length of valganciclovir prophylaxis after solid organ transplantation. Trends in Transplantation. 2008; 2(2):92-100.
  178. Cascalho M, Ogle BM, Razonable RR, West LJ, Platt JL. Cardiac transplantation in infancy: A model for dissecting immunological function. Paediatr Child Health. 2008; 18(Suppl 1):S30-S32.
  179. Pandian TK, Razonable RR. Bidirectional interaction between cytomegalovirus and hepatitis C virus after liver transplantation: A critical review of the clinical evidence. Trends in Transplantation. 2008; 3:35-43.
  180. Eid AJ, Razonable RR. Cytomegalovirus disease in solid organ transplant recipients: advances lead to new challenges and opportunities. Curr Opin Organ Transplant. 2007 Dec; 12(6):610-7.
  181. Arthurs SK, Eid AJ, Pedersen RA, Dierkhising RA, Kremers WK, Patel R, Razonable RR. Delayed-onset primary cytomegalovirus disease after liver transplantation. Liver Transpl. 2007 Dec; 13 (12):1703-9
    View PubMed
  182. Kijpittayarit-Arthurs S, Eid AJ, Kremers WK, Pedersen RA, Dierkhising RA, Patel R, Razonable RR. Clinical features and outcomes of delayed-onset primary cytomegalovirus disease in cardiac transplant recipients. J Heart Lung Transplant. 2007 Oct; 26 (10):1019-24
    View PubMed
  183. Humar A, Washburn K, Freeman R, Paya CV, Mouas H, Alecock E, Razonable RR, PV16000 Study Group. An assessment of interactions between hepatitis C virus and herpesvirus reactivation in liver transplant recipients using molecular surveillance. Liver Transpl. 2007 Oct; 13(10):1422-7.
    View PubMed
  184. Eid AJ, Davis MD, Bingham LG, Kalaaji AN, Enzler M, Razonable RR, Berbari EF. A young man with pyomyositis and bullous disease. Clin Infect Dis. 2007 Sep 15; 45(6):741, 799-800.
    View PubMed
  185. Eid AJ, Berbari EF, Sia IG, Wengenack NL, Osmon DR, Razonable RR. Prosthetic joint infection due to rapidly growing mycobacteria: report of 8 cases and review of the literature. Clin Infect Dis. 2007 Sep 15; 45(6):687-94. Epub 2007 Aug 13.
    View PubMed
  186. Eid AJ, Brown RA, Paya CV, Razonable RR. Association between toll-like receptor polymorphisms and the outcome of liver transplantation for chronic hepatitis C virus. Transplantation. 2007 Aug 27; 84(4):511-6.
    View PubMed
  187. Eid AJ, Razonable RR. Valganciclovir for the treatment of cytomegalovirus retinitis in patients with AIDS. Expert Review of Ophthalmology. 2007 Jun; 2(3):351-61.
  188. Bonatti H, Sawyer R, Dickson RC, Razonable R, Schmitt T, Mendez J, Singh N, Pruett T. Transmission of viral disease to the recipient through the donor liver. Current Opinion in Organ Transplantation. 2007 Jun; 12(3):231-41.
  189. Kijpittayarit S, Eid AJ, Brown RA, Paya CV, Razonable RR. Relationship between Toll-like receptor 2 polymorphism and cytomegalovirus disease after liver transplantation. Clin Infect Dis. 2007 May 15; 44(10):1315-20.
    View PubMed
  190. Kijpittayarit S, Razonable RR. JC virus infection after transplantation: Beyond the classic progressive multifocal leukoencephalopathy? Gastroenterol Hepatol. 2007 Jan; 3(1):74-6.
  191. Assi MA, Pulido JS, Peters SG, McCannel CA, Razonable RR. Graft-vs.-host disease in lung and other solid organ transplant recipients. Clin Transplant. 2007 Jan-Feb; 21(1):1-6.
    View PubMed
  192. Anaissie EJ, Segal BH, Graybill JR, Arndt C, Perfect JR, Kleinberg M, Pappas P, Benjamin D, Rubin R, Aberg JA, Adderson EE, Adler-Shohet FC, Akan H, Akova M, Almyroudis NG, Alexander BD, Andes D, Arrieta A, Baddley JW, Barron MA, Belzberg H, Boucher HW, Boyce TG, Casadevall A, Chandrasekar PH, Cleary JD, Cordonnier C, Cornely OA, Cuenca-Estrella M, Daly JS, Daoura N, Denning DW, dePauw B, de Repentigny L, Dignani MC, Dismukes WE, Donnelly JP, Donowitz GR, Dupont B, Drusano G, Ellis M, Espinel-Ingroff A, Fishman JA, Fleming R, Forrest G, Ghannoum M, Goldman M, Grazziutti M, Greene JN, Greenberg RN, Gubbins PO, Hadley S, Herbrecht R, Hiemenz JW, Hope W, Hospenthal DR, Husain S, Ito JI, Jacobson RM, Johnson M, Keating MR, Kett DH, Knapp K, Kontoyiannis DP, Krcmery VC, Larsen R, Laverdiere M, Ljungman P, Lortholary O, Maertens J, Marriott D, Mattiuzzi G, McGinnis MR, Morris M, Nucci M, Odds FC, Pankey GA, Patterson T, Pfaller M, Razonable RR, Reboli AC, Rinaldi MG, Roberts GD, Rodriguez Tudela JL, Rotstein C, Ruhnke M, Schuster M, Shoham S, Sia IG, Siebel N, Silviera F, Singh N, Sobel J, Solomkin JS, Sorrell TC, Steinbach WJ, Temesgen Z, Tortorano A, Vartivarian S, VerWeij P, Viscoli C, Viviani MA, Walker RC, Wheat JL, Wiley J, Williamson P, Wingard JR, Yu VL, Zaoutis T. Clinical research in the lay press: irresponsible journalism raises a huge dose of doubt. Clin Infect Dis. 2006 Oct 15; 43(8):1031-9. Epub 2006 Sep 13.
    View PubMed
  193. Eid AJ, Brown RA, Patel R, Razonable RR. Parvovirus B19 infection after transplantation: a review of 98 cases. Clin Infect Dis. 2006 Jul 1; 43(1):40-8. Epub 2006 May 12.
    View PubMed
  194. Ogle BM, West LJ, Driscoll DJ, Strome SE, Razonable RR, Paya CV, Cascalho M, Platt JL. Effacing of the T cell compartment by cardiac transplantation in infancy. J Immunol. 2006 Feb 1; 176 (3):1962-7
    View PubMed
  195. Razonable RR, Henault M, Paya CV. Stimulation of toll-like receptor 2 with bleomycin results in cellular activation and secretion of pro-inflammatory cytokines and chemokines. Toxicol Appl Pharmacol. 2006 Feb 1; 210 (3):181-9 Epub 2005 June 17
    View PubMed
  196. Razonable RR, Brown RA, Humar A, Covington E, Alecock E, Paya CV. Herpesvirus infections in solid organ transplant patients at high risk of primary cytomegalovirus disease. J Infect Dis. 2005 Oct 15; 192(8):1331-9.
    View PubMed
  197. Razonable RR, Brown RA, Humar A, Covington E, Alecock E, Paya CV. A longitudinal molecular surveillance study of human polyomavirus viremia in heart, kidney, liver, and pancreas transplant patients. J Infect Dis. 2005 Oct 15; 192(8):1349-54.
    View PubMed
  198. Humar A, Kumar D, Mazzulli T, Razonable RR, Moussa G, Paya CV, Covington E, Alecock E, Pescovitz MD. A surveillance study of adenovirus infection in adult solid organ transplant recipients. Am J Transplant. 2005 Oct; 5(10):2555-9.
    View PubMed
  199. Razonable RR, Henault M, Watson HL, Paya CV. Nystatin induces secretion of interleukin (IL)-1beta, IL-8, and tumor necrosis factor alpha by a toll-like receptor-dependent mechanism. Antimicrob Agents Chemother. 2005 Aug; 49 (8):3546-9
    View PubMed
  200. Humar A, Mazzulli T, Moussa G, Razonable RR, Paya CV, Pescovitz MD, Covington E, Alecock E. Clinical utility of cytomegalovirus (CMV) serology testing in high-risk CMV D+/R- transplant recipients. Am J Transplant. 2005 May; 5(5):1065-70.
    View PubMed
  201. Razonable RR, Henault M, Lee LN, Laethem C, Johnston PA, Watson HL, Paya CV. Secretion of proinflammatory cytokines and chemokines during amphotericin B exposure is mediated by coactivation of toll-like receptors 1 and 2. Antimicrob Agents Chemother. 2005 Apr; 49 (4):1617-21
    View PubMed
  202. Razonable RR, Emery VC, 11th Annual Meeting of the IHMF (International Herpes Management Forum). Management of CMV infection and disease in transplant patients. 27-29 February 2004. Herpes. 2004 Dec; 11(3):77-86.
    View PubMed
  203. Razonable RR, Osmon DR, Steckelberg JM. Linezolid therapy for orthopedic infections. Mayo Clin Proc. 2004 Sep; 79(9):1137-44.
    View PubMed
  204. Razonable RR, Paya CV. Valganciclovir for the prevention and treatment of cytomegalovirus disease in immunocompromised hosts. Expert Rev Anti Infect Ther. 2004 Feb; 2 (1):27-41
    View PubMed
  205. Razonable RR, Paya CV. Herpesvirus infections in transplant recipients: current challenges in the clinical management of cytomegalovirus and Epstein-Barr virus infections. Herpes. 2003 Dec; 10(3):60-5.
    View PubMed
  206. Razonable RR, Rahman AE, Wilson WR. Lemierre syndrome variant: necrobacillosis associated with inferior vena cava thrombosis and pulmonary abscesses after trauma-induced leg abscess. Mayo Clin Proc. 2003 Sep; 78 (9):1153-6
    View PubMed
  207. Razonable RR, van Cruijsen H, Brown RA, Wilson JA, Harmsen WS, Wiesner RH, Smith TF, Paya CV. Dynamics of cytomegalovirus replication during preemptive therapy with oral ganciclovir. J Infect Dis. 2003 Jun 1; 187(11):1801-8. Epub 2003 May 09.
    View PubMed
  208. Razonable RR, Rivero A, Brown RA, Hart GD, Espy MJ, van Cruijsen H, Wilson J, Groettum C, Kremers W, Smith TF, Paya CV. Detection of simultaneous beta-herpesvirus infections in clinical syndromes due to defined cytomegalovirus infection. Clin Transplant. 2003 Apr; 17 (2):114-20
    View PubMed
  209. Feldstein AE, Razonable RR, Boyce TG, Freese DK, El-Youssef M, Perrault J, Paya CV, Ishitani MB. Prevalence and clinical significance of human herpesviruses 6 and 7 active infection in pediatric liver transplant patients. Pediatr Transplant. 2003 Apr; 7 (2):125-9
    View PubMed
  210. Razonable RR, Burak KW, van Cruijsen H, Brown RA, Charlton MR, Smith TF, Espy MJ, Kremers W, Wilson JA, Groettum C, Wiesner R, Paya CV. The pathogenesis of hepatitis C virus is influenced by cytomegalovirus. Clin Infect Dis. 2002 Oct 15; 35(8):974-81.
    View PubMed
  211. Razonable RR, Paya CV. beta-Herpesviruses in transplantation. Reviews in Medical Microbiology. 2002 Oct; 13(4):163-76.
  212. Razonable RR, Paya CV. The impact of human herpesvirus-6 and-7 infection on the outcome of liver transplantation. Liver Transpl. 2002 Aug; 8(8):651-8.
    View PubMed
  213. Razonable RR, Litzow MR, Khaliq Y, Piper KE, Rouse MS, Patel R. Bacteremia due to viridans group Streptococci with diminished susceptibility to Levofloxacin among neutropenic patients receiving levofloxacin prophylaxis. Clin Infect Dis. 2002 Jun 1; 34(11):1469-74. Epub 2002 May 07.
    View PubMed
  214. Burak KW, Kremers WK, Batts KP, Wiesner RH, Rosen CB, Razonable RR, Paya CV, Charlton MR. Impact of cytomegalovirus infection, year of transplantation, and donor age on outcomes after liver transplantation for hepatitis C. Liver Transpl. 2002 Apr; 8(4):362-9.
    View PubMed
  215. Razonable RR, Brown RA, Wilson J, Groettum C, Kremers W, Espy M, Smith TF, Paya CV. The clinical use of various blood compartments for cytomegalovirus (CMV) DNA quantitation in transplant recipients with CMV disease. Transplantation. 2002 Mar 27; 73 (6):968-73
    View PubMed
  216. Razonable RR, Paya CV, Smith TF. Role of the laboratory in diagnosis and management of cytomegalovirus infection in hematopoietic stem cell and solid-organ transplant recipients. J Clin Microbiol. 2002 Mar; 40 (3):746-52
    View PubMed
  217. Razonable RR, Fanning C, Brown RA, Espy MJ, Rivero A, Wilson J, Kremers W, Smith TF, Paya CV. Selective reactivation of human herpesvirus 6 variant a occurs in critically ill immunocompetent hosts. J Infect Dis. 2002 Jan 1; 185(1):110-3. Epub 2001 Dec 14.
    View PubMed
  218. Razonable RR, Paya CV. Fungal infections in liver transplantation: Prophylaxis, surveillance, and treatment. Current Opinion in Organ Transplantation. 2002; 7(2):137-43.
  219. Razonable RR, Brown RA, Espy MJ, Rivero A, Kremers W, Wilson J, Groettum C, Smith TF, Paya CV. Comparative quantitation of cytomegalovirus (CMV) DNA in solid organ transplant recipients with CMV infection by using two high-throughput automated systems. J Clin Microbiol. 2001 Dec; 39 (12):4472-6
    View PubMed
  220. Razonable RR, Rivero A, Rodriguez A, Wilson J, Daniels J, Jenkins G, Larson T, Hellinger WC, Spivey JR, Paya CV. Allograft rejection predicts the occurrence of late-onset cytomegalovirus (CMV) disease among CMV-mismatched solid organ transplant patients receiving prophylaxis with oral ganciclovir. J Infect Dis. 2001 Dec 1; 184(11):1461-4. Epub 2001 Oct 23.
    View PubMed
  221. Razonable RR, Aksamit AJ, Wright AJ, Wilson JW. Cidofovir treatment of progressive multifocal leukoencephalopathy in a patient receiving highly active antiretroviral therapy. Mayo Clin Proc. 2001 Nov; 76 (11):1171-5
    View PubMed
  222. Razonable RR, Lewallen DG, Patel R, Osmon DR. Vertebral osteomyelitis and prosthetic joint infection due to Staphylococcus simulans. Mayo Clin Proc. 2001 Oct; 76(10):1067-70.
    View PubMed
  223. Razonable RR, Patel R, Wilhelm MP, Gertz MA, Litzow MR, Inwards DJ, Dearani JA, Edwards BS, McGregor CG. Fatal disseminated aspergillosis following sequential heart and stem cell transplantation for systemic amyloidosis. Am J Transplant. 2001 May; 1 (1):93-5
    View PubMed